Showing results (211-220 of 467) with videos related to
Sort By:
Pageof 47
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 19, 2026
Atherosclerosis burden across subtypes of steatotic liver disease: a European cohort analysisJohannes Bauer, Sophie Gensluckner, Julian Eberhardt, et al.Frontiers in Pharmacology|April 17, 2023
Bacterial growth and ceftriaxone activity in individual ascitic fluids in an in vitro model of spontaneous bacterial peritonitisWisse van Os, Beatrix Wulkersdorfer, Sabine Eberl, et al.Journal of Gastroenterology and Hepatology|May 11, 2016
Plasma renin concentration represents an independent risk factor for mortality and is associated with liver dysfunction in patients with cirrhosisRafael Paternostro, Thomas Reiberger, Mattias Mandorfer, et al.Journal of Medical Virology|December 25, 2010
Molecular epidemiology of chronic hepatitis B virus infection in GreeceAsimina Fylaktou, Fylaktou Asimina, Dimitrios Papaventsis, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 18, 2019
The value of different CT-based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosisRafael Paternostro, Katharina Lampichler, Constanze Bardach, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 18, 2017
Transferrin as a predictor of survival in cirrhosisAndré Viveiros, Armin Finkenstedt, Benedikt Schaefer, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|May 11, 2018
Pharmacological decrease of liver stiffness is pressure-related and predicts long-term clinical outcomeFelix Piecha, Mattias Mandorfer, Teresa Peccerella, et al.Platelets|March 16, 2022
Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosisKsenia Brusilovskaya, Benedikt Simbrunner, Silvia Lee, et al.Journal of Virus Eradication|September 4, 2023
CHIME - A tailored HCV microelimination project in Viennese people who inject drugs at drug centralized substitution centersCaroline Schwarz, Raphael Schubert, Michael Schwarz, et al.Plos One|March 11, 2020
Directly observed therapy for HCV with glecaprevir/pibrentasvir alongside opioid substitution in people who inject drugs-First real world data from AustriaCaroline Schmidbauer, Raphael Schubert, Angelika Schütz, et al.Pageof 47